Lonza Group AG LZAGF

Company Overview

Lonza Group AG is a Swiss-based global manufacturing partner to the pharmaceutical, biotechnology, and specialty chemicals industries, with a primary focus on life sciences. The company operates as a contract development and manufacturing organization (CDMO), providing services that support the development and commercialization of biopharmaceuticals, advanced therapies, and consumer health products. Lonza’s core role is enabling customers to bring complex products to market by supplying development expertise, manufacturing scale, and regulatory-compliant production.

The company’s primary revenue drivers are biologics manufacturing, small molecule active pharmaceutical ingredient (API) production, cell and gene therapy services, and pharmaceutical capsules. Lonza serves large pharmaceutical companies, emerging biotechnology firms, and consumer health manufacturers. Its strategic advantages include long-term customer contracts, high switching costs, deep regulatory expertise, and specialized manufacturing infrastructure. Founded in 1897 as an electricity producer in Switzerland, Lonza evolved into a chemical company and, over decades, transitioned toward life sciences, culminating in its current focus on healthcare manufacturing and development services.